Mu receptors activation

The selectivity of currently used delta agonists may not be sufficient to avoid mu receptor activation in vivo. As an example, one study showed that DPDPE (selectivity delta/mu 100-fold) injected either ICV or ITH was less active in the mu receptor mutant than deltorphin (selectivity mu/delta 10,000-fold) [60]. This suggests that, in WT mice the less delta selective compound recruits mu receptors to produce analgesia in the tail flick and hot plate tests under their experimental conditions. 

In conclusion, the in vivo activity of available delta opioids is complex. DPDPE, or even Delt, administered ICV seems to recruit mu receptors and, from all the data, it appears that delta agonists often have mixed mu/ delta activities. More selective delta agonists need to be produced to explore delta receptor pharmacology. The examination of nonanalgesic activities of delta ligands in opioid receptor knockout mice has been very informative while the convulsive effect of SNC 80 seems indeed delta receptor mediated, the addictive activity of Delt most probably results from mu receptor activation and the immunosuppressive action of NTI is mediated by a nonopioid mechanism. 

RVM modulatory system, but do not play a critical role in the response to mu receptor activation within the PAG or RVM itself, or when the mu agonist is given systemically or ICV so that multiple levels of the system are activated in concert. 

Morphine is the prototype for the class of natural and synthetic opioid analgesics and its toxicity stems mainly from its extensive effect on the central nervous system (CNS), principally that of a descending depression. Opioids interact with stereospecific and saturable binding sites mostly located in the CNS. Interaction with the opioid receptors mimics the actions of endogenous enkephalins and endorphins. Morphine is a pure opiate agonist and exerts its activity primarily on the mu receptor. Activity also appears to involve an alteration in the release of neurotransmitters, such as the inhibition of acetylcholine, norepinepherine, and dopamine. These actions result in the therapeutic effects of analgesia, sedation, euphoria, and decreased gastrointestinal motility however, in toxic amounts they can lead to... 

Breivogel, C. S Selley, D. E., and Childers, S. R. (1997) Acute and chronic effects of opioids on delta and mu receptor activation of G-proteins in NG108-15 and SK-N-SH cell membranes. J. Neurochem. 68,1462-1472. 

Figure 21.5 Mechanisms of opioid analgesia at the spinal level. Action potentials in nociceptive afferent fibres invade the terminal and by opening calcium channels (L, N and P-type) cause the release of glutamate and peptides that further transmit pain subsequent to activation of their postsynaptic receptors. Presynaptic opioid receptor activation (mu- and delta-mediated effects have been most clearly shown) opens potassium channels which hyperpolarise the terminal, so reducing transmitter release and inhibiting the postsynaptic neuron...

Sawynok J. (1995). Pharmacological rationale for the clinical use of caffeine. Drugs. 49(1) 37-50. Sawynok J. (1998). Adenosine receptor activation and nociception. Eur J Pharmacol. 347(1) 1-11. Schlaepfer TE, Strain EC, Greenberg BD, Preston KL, Lancaster E, Bigelow GE, Barta PE, Pearlson GD. (1998). Site of opioid action in the human brain mu and kappa agonists subjective and cerebral blood flow effects. Am J Psychiatry. 155(4) 470-73. 

Both U-62066 (spiradoline) (10) and PD 117302 (12) are racemic mixtures of two enantiomers. The kappa opioid activity has been shown to reside in the (—) enantiomer, and in the case of U62066 the (-h) enantiomer is a weak mu receptor agonist [49, 50]. (See above for discussion on absolute stereochemistry.)... 

Delta receptor activation also produces analgesia, but it can also cause seizures as well. Delta receptors normally bind to a class of endogenous ligands known as enkephalins, but unlike mu receptors, information about delta receptors is limited. Enkephalins are peptides that are produced by the pituitary gland. Several different enkephalins have been identified. [3-Enkephalin resembles opiates because when it binds to a delta receptor, it relieves pain.11... 

Hydrocodone is a semisynthetic opioid derived from codeine.18It is utilized as an analgesic and antitussive available for oral administration, often in combination with acetaminophen or ibuprofen. As a rule, potent analgesics containing a methoxyl group at position 3 (e.g., hydrocodone, K, = 19.8 nM) bind the mu receptor relatively weakly, but their O-demethylated metabolites (such as hydromorphone, Kt = 0.6 nM) bind more strangely. As with oxycodone, the possibility exists that some of their ability to relieve pain may actually derive from their active metabolites 48... 

Buprenorphine is derived from thebaine. It is a partial mu agonist with kappa antagonist activity. Buprenorphine has 25 to 50 times the potency of morphine. It is used to produce a longer-lasting analgesia than morphine. Effects of buprenorphine last longer because it is released more slowly from mu receptors than morphine. It is available as an injectable for intramuscular (IM) or intravenous administration in a 1-ml solution containing 0.3 mg buprenorphine (as buprenorphine HC1) for the relief of moderate to severe pain. It is also available to treat opioid dependence in the formulation of a tablet,51 alone or in combination with naloxone, in 2- or 8-mg... 

A new addition to this category is buprenorphine (Buprenex). This drug partially activates mu receptors but is an antagonist at kappa receptors. Because of these selective effects, buprenorphine has been advocated not only as an analgesic, but also as a treatment for opioid dependence and withdrawal.26 84 The use of this drug in treating opioid addiction is discussed in more detail later in this chapter. 

Finnegan TF, Chen SR, Pan HL (2006) Mu opioid receptor activation inhibits GABAergic inputs to basolateral amygdala neurons through Kvl.1/1.2 channels. J Neurophysiol 95 2032-41 Fu LY, Acuna-Goycolea C, van den Pol (2004) Neuropeptide Y inhibits hypocretin/orexin neurons by multiple presynaptic and postsynaptic mechanisms tonic depression of the hypothalamic arousal system. J Neurosd 24 8741-51... 

All opioids produce their effect by activating one or more of the three types of receptors. Thus analgesia involves the activation of the mu receptors that are located mainly at supraspinal sites and kappa receptors in the spinal cord delta receptors may also be involved but their relative contribution is unclear. Nevertheless, the actions of the opioids on these receptors is complex, as there is evidence that the same substance may act as a full agonist, or as an antagonist at different sites within the brain. 

Mutagenesis of intracellular faces of transmembrane domains of mu receptors revealed molecular determinants for receptor activation within the helical bundle and located underneath the ligand binding pocket. Several mu-... 

Biological activity Compound Delta receptor KO (52) Mu receptor KO... 

Beyond delta agonist selectivity and mu or delta receptor availability in vivo, the observation of decreased delta agonist efficacy in mice lacking mu receptors could also be explained by functional cooperation of mu and delta receptors. It is likely that some delta receptor-mediated effects require mu receptors for full activity (see Rothman and Xu, Chap. 21). Where in the brain, and whether this occurs between receptors located in the same neurons or on different neurons within neural circuits, remains to be determined. 

---